Leaf Energy is an Australian technology company which is primarily focused on creating a leading plant biotechnology business to produce biofuels, high value commercial proteins and other plant derived compounds. There PCT application is due to be published on 6th December, 2012. This application is regarding pre treatment of biomass for bio-ethanol production. This [...]
Claims are most important part of the patent as they define legal scope of the patent. Hence they should be carefully drafted. During coming month I will be writing about various tips for patent claim drafting. For quick glance, in this blog am a just giving 8 quick tips to write claims – TIP [...]
On 18 th September 2012, Microsoft Corp. announced that they have signed a patent licensing agreement with Reliance In Motion (RIM) that gives RIM access to the latest Extended File Allocation Table (exFAT) for certain BlackBerry® devices. The need for a common file system for data sharing across multiple platforms and products have increased [...]
A patent is a statutory privilege granted by the Government to an inventor, and to other persons deriving their rights from the inventor (Eg: Assignee) for a fixed period of years, to exclude other persons from manufacturing, using or selling a patented product, or from utilizing a patented method or process. At the expiration [...]
Patents on pharmaceuticals are a contentious issue for many countries around the world, for the obvious reason that the average person in most countries can’t afford to pay for brand-name drugs. The patent battle over Glivec is, needless to say, bitter and complicated. The argument for providing a patent to glivec (imatinib mesylate), a [...]
Hyderabad based Natco Pharma, which successfully received India’s first compulsory license for Nexavar (cancer drug) is again in news for patent dispute with Bristol-Myers Squibb (BMS). Dispute relates to generic version of Dasatinib, crucial medicine used in chronic myeloid leukemia. Natco is selling under brand name Sprycel.Natco has gone ahead and launched a generic [...]
